- Home
- WU vs VCYT Comparison
WU vs VCYT Comparison
Compare WU & VCYT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | WU | VCYT |
|---|---|---|
| Founded | 1851 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.7B | 2.9B |
| IPO Year | 2006 | 2013 |
Fundamental Metrics
Financial Performance| Metric | WU | VCYT |
|---|---|---|
| Price | $8.76 | $46.59 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 10 | 9 |
| Target Price | $8.75 | ★ $44.44 |
| AVG Volume (30 Days) | ★ 8.2M | 1.2M |
| Earning Date | 10-23-2025 | 11-04-2025 |
| Dividend Yield | ★ 10.80% | N/A |
| EPS Growth | ★ 18.91 | N/A |
| EPS | ★ 2.32 | 0.38 |
| Revenue | ★ $4,100,500,000.00 | $495,141,000.00 |
| Revenue This Year | $0.08 | $16.02 |
| Revenue Next Year | $0.59 | $10.74 |
| P/E Ratio | ★ $3.75 | $122.79 |
| Revenue Growth | N/A | ★ 16.41 |
| 52 Week Low | $7.85 | $22.61 |
| 52 Week High | $11.95 | $50.71 |
Technical Indicators
Market Signals| Indicator | WU | VCYT |
|---|---|---|
| Relative Strength Index (RSI) | 51.67 | 64.28 |
| Support Level | $8.14 | $37.98 |
| Resistance Level | $8.84 | $50.71 |
| Average True Range (ATR) | 0.25 | 2.07 |
| MACD | -0.02 | 0.37 |
| Stochastic Oscillator | 57.62 | 67.32 |
Price Performance
Historical ComparisonAbout WU Western Union Company (The)
Western Union provides domestic and international money transfers through its global network of over 500,000 outside agents. The company handled almost 290 million transactions in 2024 and is the largest money transfer company in the world.
About VCYT Veracyte Inc.
Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder). In addition, its Percepta Nasal Swab test is being run in CLIA labs in support of clinical studies.